YS43-22

(4S,4aS,5aS,13aS,15aS,15bR)-6-methyl-3,4,4a,5,5a,7,8,13a,15,15a,15b,16-dodecahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-6-ium-14-one,chloride

21α,22-Dihydrostrychnidine

19,22-Dimethyltetracontan

SF-22 (TRPML3 activator)

7,22-dihydro-8,21-dioxa-tetranaphtho[2,1-b:1',2'-d:2'',1''-h:1''',2'''-j]cyclododecene

Ergosten-(22)-triol-(3α,5α,8α)

2-[1-methyl-4-(propan-2-yl)-1H-pyrazol-3-yl]ethan-1-ol

2-[(1s,4s)-2-Azabicyclo[2.2.2]octan-3-yl]ethan-1-ol

2-(Azetidin-3-yl)cyclopentan-1-ol

(2S,3S)-2-[2-cyclobutyl-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]-3-methylpentanoic acid

3-(2-Ethyl-1-hydroxybutan-2-yl)azetidin-3-ol

1-Ethynyl-2,2-difluorobicyclo[3.1.0]hexane

4-Amino-1-methyl-5-(1-methylcyclobutyl)pyrrolidin-2-one

Methyl 4-fluoro-8-oxa-2-azaspiro[4.5]decane-4-carboxylate

1-[(2R,3S)-3-(benzyloxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanoyl]-2-methylpyrrolidine-3-carboxylic acid

1-[3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl]ethan-1-one